Patent · US Expired

Antiviral combinations and compounds therefor

US5175165A · kind A · utility

2Cited by
5References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 1989
Grant dateDec 29, 1992
Priority date
Expiry dateJun 26, 2009

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel ribonucleotide reductase inhibitors and new combinations comprising an antiviral compound, such as acyclovir, and a thiocarbonohydrazone ribonucleotide reductase inhibitor for the chemotherapeutic treatment of virus infections, espectially viruses of the herpes group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.